Statistics for 1-Aryl-3-[4-(thieno[3,2-d]pyrimidin-4-yloxy)phenyl]ureas as VEGFR2 tyrosine kinase inhibitors: synthesis, docking studies, enzymatic and cellular assays
Total visits
| views | |
|---|---|
| 1-Aryl-3-[4-(thieno[3,2-d]pyrimidin-4-yloxy)phenyl]ureas as VEGFR2 tyrosine kinase inhibitors: synthesis, docking studies, enzymatic and cellular assays | 611 |
Total visits per month
| views | |
|---|---|
| December 2024 | 5 |
| January 2025 | 5 |
| February 2025 | 5 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 1 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| Poster Int. 72.pdf(legacy) | 483 |
| Poster Int. 72.pdf | 6 |
| Poster Int. 72-74.pdf(legacy) | 2 |
| paper_xoconostle_FRI_revised.pdf(legacy) | 1 |
| Legs para sideração.pdf(legacy) | 1 |
| Pires_Bianca.pdf(legacy) | 1 |
Top country views
| views | |
|---|---|
| United States | 148 |
| Germany | 92 |
| China | 80 |
| Russia | 58 |
| Portugal | 44 |
| United Kingdom | 38 |
| Ukraine | 29 |
| France | 14 |
| Netherlands | 10 |
| European Union | 8 |
| Belarus | 7 |
| Poland | 5 |
| Turkey | 5 |
| Brazil | 4 |
| Belgium | 3 |
| Ireland | 3 |
| Italy | 3 |
| Japan | 3 |
| South Korea | 3 |
| India | 2 |
| Sweden | 2 |
| Canada | 1 |
| Switzerland | 1 |
| Cape Verde | 1 |
| Denmark | 1 |
| Egypt | 1 |
| Spain | 1 |
| Hungary | 1 |
| Israel | 1 |
| Lithuania | 1 |
| Latvia | 1 |
| Pakistan | 1 |
| South Africa | 1 |